THE PREVALENCE AND ETIOLOGY OF LONG-TERM L-DOPA SIDE-EFFECTS IN ELDERLY PARKINSONIAN-PATIENTS

被引:17
作者
WILSON, JA
SMITH, RG
机构
关键词
D O I
10.1093/ageing/18.1.11
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:11 / 16
页数:6
相关论文
共 27 条
[11]  
GRANERUS AK, 1979, ADV NEUROL, V24, P327
[12]  
HOEN MM, 1967, NEUROLOGY, V17, P427
[13]   MEASUREMENT OF MENTAL IMPAIRMENT IN GERIATRIC PRACTICE [J].
ISAACS, B ;
WALKEY, FA .
GERONTOLOGIA CLINICA, 1964, 6 (02) :114-&
[14]  
JENKINS RB, 1970, LANCET, V2, P177
[15]   EVIDENCE TO SUPPORT EARLY LEVODOPA THERAPY IN PARKINSON DISEASE [J].
MARKHAM, CH ;
DIAMOND, SG .
NEUROLOGY, 1981, 31 (02) :125-131
[16]  
MARSDEN CD, 1977, LANCET, V1, P345
[17]   THE ON OFF PHENOMENON IN PARKINSONS-DISEASE - RELATION TO LEVODOPA ABSORPTION AND TRANSPORT [J].
NUTT, JG ;
WOODWARD, WR ;
HAMMERSTAD, JP ;
CARTER, JH ;
ANDERSON, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (08) :483-488
[18]   BROMOCRIPTINE IN PARKINSONISM [J].
PEARCE, I ;
PEARCE, JMS .
BRITISH MEDICAL JOURNAL, 1978, 1 (6124) :1402-1404
[19]   L-DOPA LONG-TERM TREATMENT IN PARKINSONS-DISEASE - AGE-RELATED SIDE-EFFECTS [J].
PEDERZOLI, M ;
GIROTTI, F ;
SCIGLIANO, G ;
AIELLO, G ;
CARELLA, F ;
CARACENI, T .
NEUROLOGY, 1983, 33 (11) :1518-1521
[20]  
PENTLAND B, 1982, SCOTT MED J, V27, P234